We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
+4.26%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+476.55%
AUM
$306B
AUM Growth
+$2.16B
Cap. Flow
-$5.61B
Cap. Flow %
-1.83%
Top 10 Hldgs %
15.38%
Holding
7,605
New
546
Increased
3,268
Reduced
2,864
Closed
595

Sector Composition

Rank Sector Weight
1 Financials 8.2%
2 Technology 7.55%
3 Healthcare 7.22%
4 Energy 6.62%
5 Consumer Discretionary 6.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NXEO
5851
DELISTED
Nexeo Solutions, Inc. Common Stock
NXEO
$136K ﹤0.01%
+15,188
New +$149K
NWY
5852
DELISTED
New York & Co Inc
NWY
$136K ﹤0.01%
90,982
-34,833
-28% -$93.4K
COB
5853
DELISTED
CommunityOne Bancorp
COB
$136K ﹤0.01%
+10,750
New +$142K
AXSM icon
5854
Axsome Therapeutics
AXSM
$11.7B
$135K ﹤0.01%
+17,854
New +$164K
CPRX
5855
DELISTED
Catalyst Pharmaceutical
CPRX
$135K ﹤0.01%
189,607
+87,752
+86% +$70.7K
NCLH icon
5856
PUT
Norwegian Cruise Line
NCLH
$9.53B
$135K ﹤0.01%
3,400
-117,400
-97% -$5.6M
TDC icon
5857
CALL
Teradata
TDC
$2.88B
$135K ﹤0.01%
5,400
+5,100
+1,700% +$135K
TVRD
5858
Tvardi Therapeutics
TVRD
$20.1M
$135K ﹤0.01%
782
+430
+122% +$93.6K
ACFC
5859
DELISTED
Atlantic Coast Financial Corporation
ACFC
$135K ﹤0.01%
+22,515
New +$140K
RDN icon
5860
PUT
Radian Group
RDN
$5.28B
$134K ﹤0.01%
12,900
+6,600
+105% +$77.7K
TGH
5861
DELISTED
Textainer Group Holdings limited
TGH
$134K ﹤0.01%
12,035
-18,849
-61% -$250K
PF
5862
CALL
DELISTED
Pinnacle Foods, Inc.
PF
$134K ﹤0.01%
2,900
+1,300
+81% +$56.5K
DSCI
5863
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
$134K ﹤0.01%
34,096
+4,521
+15% +$16.9K
TDC icon
5864
PUT
Teradata
TDC
$2.88B
$133K ﹤0.01%
5,300
+2,200
+71% +$58.4K
AVH
5865
CALL
DELISTED
AVIANCA HOLDINGS S.A.
AVH
$133K ﹤0.01%
+21,600
New +$126K
VIAB
5866
PUT
DELISTED
Viacom Inc. Class B
VIAB
$133K ﹤0.01%
3,200
-57,900
-95% -$2.39M
ARCC icon
5867
CALL
Ares Capital
ARCC
$13.4B
$132K ﹤0.01%
9,300
-1,600
-15% -$23.7K
ARCT icon
5868
Arcturus Therapeutics
ARCT
$165M
$132K ﹤0.01%
4,212
+1,875
+80% +$59.1K
POST icon
5869
PUT
Post Holdings
POST
$4.42B
$132K ﹤0.01%
2,445
-25,059
-91% -$1.21M
LMIA
5870
DELISTED
LMI Aerospace Inc
LMIA
$132K ﹤0.01%
16,367
+4,831
+42% +$41.1K
DCOY
5871
Decoy Therapeutics
DCOY
$2.14M
0
MDC
5872
CALL
DELISTED
M.D.C. Holdings, Inc.
MDC
$131K ﹤0.01%
7,500
+1,945
+35% +$33.6K
NSTG
5873
DELISTED
NanoString Technologies, Inc.
NSTG
$131K ﹤0.01%
+10,417
New +$151K
DRNA
5874
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$130K ﹤0.01%
43,469
+12,297
+39% +$50.5K
GAIN icon
5875
Gladstone Investment Corp
GAIN
$642M
$129K ﹤0.01%
17,961
-4,796
-21% -$33.4K

Similar funds

Goldman Sachs's Q2 2016 Portfolio in Review

As of Q2 2016, Goldman Sachs held 7,605 positions worth $306B, up 0.71% from $304B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Goldman Sachs's Q2 2016 filing shows 546 new, 3,268 increased, 2,864 reduced and 595 closed positions. Its largest new stake was Liberty Media Corporation Series C Liberty SiriusXM Common Stock: 3,735,711 shares worth $87.8M. The largest sale was Pfizer, an estimated $2.27B.

By sector, the portfolio is most concentrated in Financials at 8.2% of assets, down from 8.6% a quarter earlier, followed by Technology and Healthcare.

  • Goldman Sachs's largest Q2 2016 buy was Liberty Media Corporation Series C Liberty SiriusXM Common Stock: 3,735,711 shares worth $87.8M.
  • Goldman Sachs added most to Hilton Worldwide in Q2 2016, an estimated $717M increase.
  • Goldman Sachs's biggest Q2 2016 reduction was Pfizer, cutting an estimated $2.27B.
  • Goldman Sachs fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $1.05B.
  • Goldman Sachs's ten largest holdings make up 15% of its $306B portfolio in Q2 2016.
  • Goldman Sachs opened 546 new positions and closed 595 in Q2 2016.
  • Goldman Sachs's portfolio value rose 0.71% quarter-over-quarter to $306B.

Based on Goldman Sachs's 13F filing for Q2 2016, filed 15 Aug 2016.